BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27759555)

  • 41. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease.
    Jhang JS; Schilsky ML; Lefkowitch JH; Schwartz J
    J Clin Apher; 2007 Feb; 22(1):10-4. PubMed ID: 17285615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A simple and rapid stain for copper in liver tissue.
    Emanuele P; Goodman ZD
    Ann Diagn Pathol; 1998 Apr; 2(2):125-6. PubMed ID: 9845729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease.
    Weiss KH; Schäfer M; Gotthardt DN; Angerer A; Mogler C; Schirmacher P; Schemmer P; Stremmel W; Sauer P
    Clin Transplant; 2013; 27(6):914-22. PubMed ID: 24118554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic histochemistry in hepatic pathology.
    Iezzoni JC
    Semin Diagn Pathol; 2018 Nov; 35(6):381-389. PubMed ID: 30409459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Auxiliary Partial Orthotopic Living Liver Transplant for Wilson Disease.
    Haberal M; Akdur A; Moray G; Boyacioglu S; Torgay A; Arslan G; Arslan G; Ozdemir BH
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):182-184. PubMed ID: 28260463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver transplantation for neuropsychiatric Wilson disease.
    Kassam N; Witt N; Kneteman N; Bain VG
    Can J Gastroenterol; 1998; 12(1):65-8. PubMed ID: 9544415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The significance of variations in the distribution of copper in liver disease.
    Goldfischer S; Popper H; Sternlieb I
    Am J Pathol; 1980 Jun; 99(3):715-30. PubMed ID: 7386600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Revisiting the topic of histochemically detectable copper in various liver diseases with special focus on venous outflow impairment.
    Mounajjed T; Oxentenko AS; Qureshi H; Smyrk TC
    Am J Clin Pathol; 2013 Jan; 139(1):79-86. PubMed ID: 23270902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Clinical Utility of a Low Serum Ceruloplasmin Measurement in the Diagnosis of Wilson Disease.
    Kelly D; Crotty G; O'Mullane J; Stapleton M; Sweeney B; O'Sullivan SS
    Ir Med J; 2016 Jan; 109(1):341-3. PubMed ID: 26904791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcomes of patients with Wilson disease in a large Austrian cohort.
    Beinhardt S; Leiss W; Stättermayer AF; Graziadei I; Zoller H; Stauber R; Maieron A; Datz C; Steindl-Munda P; Hofer H; Vogel W; Trauner M; Ferenci P
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):683-9. PubMed ID: 24076416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.
    Zhou XX; Qin HL; Li XH; Huang HW; Liang YY; Liang XL; Pu XY
    Neurol India; 2014; 62(4):362-6. PubMed ID: 25237939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative exchangeable copper: A valuable tool for the diagnosis of Wilson disease.
    Guillaud O; Brunet AS; Mallet I; Dumortier J; Pelosse M; Heissat S; Rivet C; Lachaux A; Bost M
    Liver Int; 2018 Feb; 38(2):350-357. PubMed ID: 28719006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Morpholine-dithiocarbamat: a new histochemical method for the demonstration of copper in tissue in Morbus Wilson (author's transl)].
    Höfler H; Wawschinek O
    Mikroskopie; 1977 Oct; 33(7-8):185-9. PubMed ID: 927632
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Copper metabolism after living related liver transplantation for Wilson's disease].
    Wang XH; Cheng F; Zhang F; Li XC; Li GQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):303. PubMed ID: 15161511
    [No Abstract]   [Full Text] [Related]  

  • 56. Special stains in diagnostic liver pathology.
    Lefkowitch JH
    Semin Diagn Pathol; 2006; 23(3-4):190-8. PubMed ID: 17355092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does Liver Transplant Improve Neurological Symptoms in Wilson Disease? Report of 24 Cases.
    Aksoy F; Arslan İE; Ozgur T; Dundar HZ; Çelik F; Bican Demir A; Erer Ozbek S; Kiyici M; Ozkan TB; Kaya E
    Exp Clin Transplant; 2022 Nov; 20(11):1009-1015. PubMed ID: 36524887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metallothionein immunohistochemistry has high sensitivity and specificity for detection of Wilson disease.
    Rowan DJ; Mangalaparthi KK; Singh S; Moreira RK; Mounajjed T; Lamps L; Westerhoff M; Cheng J; Bellizzi AM; Allende DS; Pandey A; Graham RP
    Mod Pathol; 2022 Jul; 35(7):946-955. PubMed ID: 34934154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reference limits for copper and iron in liver biopsies.
    Nuttall KL; Palaty J; Lockitch G
    Ann Clin Lab Sci; 2003; 33(4):443-50. PubMed ID: 14584759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is it possible to diagnose Wilson disease with a piece of skin?
    Eşrefoğlu M; Gül M; Seyhan M; Selimoğlu MA
    Ultrastruct Pathol; 2009 Dec; 33(6):265-8. PubMed ID: 19929173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.